Skip to main content
Erschienen in: Virchows Archiv 3/2007

01.09.2007 | Case Report

Postmortem diagnosis of Fabry disease with acromegaly and a unique vasculopathy

verfasst von: Masaki Takao, Taisuke Mori, Hideki Orikasa, Haengphil Oh, Kinuko Suzuki, Atsuo Koto, Kazuto Yamazaki

Erschienen in: Virchows Archiv | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

A 44-year-old Japanese man with elevated growth hormone levels and gradual deterioration of mental and renal function was admitted to the hospital. With his deteriorated general condition and renal failure, the patient developed pulmonary thromboembolism and died of respiratory failure. Autopsy examination was conducted, which revealed abnormal accumulation or intracytoplasmic storage of lipid-rich material in the small blood vessels, kidney, heart, and nervous system. After postmortem pathologic studies, including light-microscopic histochemistry, electron microscopy, and biochemical analysis of the stored lipid contents, a final diagnosis of Fabry disease was made. Histopathologic examination revealed a unique vasculopathy characterized by the presence of abnormal intracytoplasmic lipid inclusions and vascular remodeling. With regard to the clinical presentation of acromegaly, hyperplasia but not adenomatous transformation of the acidophils of the anterior pituitary gland with immunohistochemical detection of growth hormone within the cells was noted. In this case, the complication of acromegaly with hyperplasia of the acidophilic cells of the anterior pituitary gland and the unique vasculopathy causing significant organ failure, mainly of the kidney, heart, and central nervous systems, possibly as a result of microcirculatory failure, are considered to be not incidental findings but to be intimately involved in the pathogenesis of Farby disease.
Literatur
1.
Zurück zum Zitat Anderson W (1898) A case of ‘Angiokeratoma’. Br J Dermatol 10:113–117CrossRef Anderson W (1898) A case of ‘Angiokeratoma’. Br J Dermatol 10:113–117CrossRef
2.
Zurück zum Zitat Bernstein HS, Bishop DF, Astrin KH, Kornreich R, Eng CM, Sakuraba H, Desnick RJ (1989) Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. J Clin Invest 83:1390–1399PubMed Bernstein HS, Bishop DF, Astrin KH, Kornreich R, Eng CM, Sakuraba H, Desnick RJ (1989) Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. J Clin Invest 83:1390–1399PubMed
3.
Zurück zum Zitat Colucci WS, Lorell BH, Schoen FJ, Warhol MJ, Grossman W (1982) Hypertrophic obstructive cardiomyopathy due to Fabry’s disease. N Engl J Med 307:926–928PubMedCrossRef Colucci WS, Lorell BH, Schoen FJ, Warhol MJ, Grossman W (1982) Hypertrophic obstructive cardiomyopathy due to Fabry’s disease. N Engl J Med 307:926–928PubMedCrossRef
4.
Zurück zum Zitat Dabbs D (2002) Diagnositic immunohistochmeistry. Churchill Livingstone, New York Dabbs D (2002) Diagnositic immunohistochmeistry. Churchill Livingstone, New York
5.
Zurück zum Zitat Dempsey H, Hartley MW, Carroll J, Balint J, Miller RE, Frommeyer WB Jr (1965) Fabry’s disease (angiokeratoma corporis diffusum): case report on a rare disease. Ann Intern Med 63:1059–1068PubMed Dempsey H, Hartley MW, Carroll J, Balint J, Miller RE, Frommeyer WB Jr (1965) Fabry’s disease (angiokeratoma corporis diffusum): case report on a rare disease. Ann Intern Med 63:1059–1068PubMed
6.
Zurück zum Zitat Desnick R, Ioannou Y, Eng C (1995) alpha-galactosidase A deficiency: Fabry disease. In: Scriver CR, Beauder AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2741–2784 Desnick R, Ioannou Y, Eng C (1995) alpha-galactosidase A deficiency: Fabry disease. In: Scriver CR, Beauder AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2741–2784
7.
Zurück zum Zitat Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B, Ledvinova J, Belohlavek M, Kral V, Dorazilova V (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry’s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417:449–455PubMedCrossRef Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B, Ledvinova J, Belohlavek M, Kral V, Dorazilova V (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry’s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417:449–455PubMedCrossRef
8.
Zurück zum Zitat Fabry J (1989) Ein Beitrag Zur Kenntnis der Purpura haemorrhagica nuduralis (Purpura papulosa hemorrhagica Hebrae). Arch Dermatol Syph 43:187–200 Fabry J (1989) Ein Beitrag Zur Kenntnis der Purpura haemorrhagica nuduralis (Purpura papulosa hemorrhagica Hebrae). Arch Dermatol Syph 43:187–200
9.
Zurück zum Zitat Fone DJ, King WE (1964) Angiokeratoma corporis diffusum (Fabry’s Syndrome). Australas Ann Med 13:339–348PubMed Fone DJ, King WE (1964) Angiokeratoma corporis diffusum (Fabry’s Syndrome). Australas Ann Med 13:339–348PubMed
10.
Zurück zum Zitat Franceschetti AT, Philippart M, Franceschetti A (1969) A study of Fabry’s disease. I. Clinical examination of a family with cornea verticillata. Dermatologica 138:209–221PubMedCrossRef Franceschetti AT, Philippart M, Franceschetti A (1969) A study of Fabry’s disease. I. Clinical examination of a family with cornea verticillata. Dermatologica 138:209–221PubMedCrossRef
11.
Zurück zum Zitat Ghadially F (1997) Ultrastructural pathology of the cell and matrix. Butterworth-Heinemann, Boston Ghadially F (1997) Ultrastructural pathology of the cell and matrix. Butterworth-Heinemann, Boston
12.
Zurück zum Zitat Ko YH, Kim HJ, Roh YS, Park CK, Kwon CK, Park MH (1996) Atypical Fabry’s disease. An oligosymptomatic variant. Arch Pathol Lab Med 120:86–89PubMed Ko YH, Kim HJ, Roh YS, Park CK, Kwon CK, Park MH (1996) Atypical Fabry’s disease. An oligosymptomatic variant. Arch Pathol Lab Med 120:86–89PubMed
13.
Zurück zum Zitat Kodama H, Hirotani T, Suzuki Y, Ogawa S, Yamazaki K (2002) Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. Am J Pathol 161:381–389PubMed Kodama H, Hirotani T, Suzuki Y, Ogawa S, Yamazaki K (2002) Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. Am J Pathol 161:381–389PubMed
14.
Zurück zum Zitat Kornreich R, Bishop DF, Desnick RJ (1989) The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease. Trans Assoc Am Physicians 102:30–43PubMed Kornreich R, Bishop DF, Desnick RJ (1989) The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease. Trans Assoc Am Physicians 102:30–43PubMed
15.
Zurück zum Zitat Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT (1997) The vascular dementia of Fabry’s disease. Dement Geriatr Cogn Disord 8:252–257PubMedCrossRef Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT (1997) The vascular dementia of Fabry’s disease. Dement Geriatr Cogn Disord 8:252–257PubMedCrossRef
16.
Zurück zum Zitat Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM, Tanaka H, Tei C, Desnick RJ (2003) Fabry disease: detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype. Kidney Int 64:801–807PubMedCrossRef Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM, Tanaka H, Tei C, Desnick RJ (2003) Fabry disease: detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype. Kidney Int 64:801–807PubMedCrossRef
17.
Zurück zum Zitat Nistal M, Paniagua R, Picazo ML (1983) Testicular and epididymal involvement in Fabry’s disease. J Pathol 141:113–124PubMedCrossRef Nistal M, Paniagua R, Picazo ML (1983) Testicular and epididymal involvement in Fabry’s disease. J Pathol 141:113–124PubMedCrossRef
18.
Zurück zum Zitat Puccio D, Coppola G, Corrado E, Muratori I, Pistone G, Buongiorno MR, Arico M, Novo S (2005) Non invasive evaluation of endothelial function in patients with Anderson–Fabry disease. Int Angiol 24:295–299PubMed Puccio D, Coppola G, Corrado E, Muratori I, Pistone G, Buongiorno MR, Arico M, Novo S (2005) Non invasive evaluation of endothelial function in patients with Anderson–Fabry disease. Int Angiol 24:295–299PubMed
19.
Zurück zum Zitat Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Lohr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R (2005) Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366:1794–1796PubMedCrossRef Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Lohr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R (2005) Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366:1794–1796PubMedCrossRef
20.
Zurück zum Zitat Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79:31–40PubMedCrossRef Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79:31–40PubMedCrossRef
21.
Zurück zum Zitat Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M (2006) Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch 448:337–343PubMedCrossRef Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M (2006) Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch 448:337–343PubMedCrossRef
22.
Zurück zum Zitat Schiffmann R (2006) The significance of lysosomal inclusions in Fabry disease. Virchows Arch 449:134PubMedCrossRef Schiffmann R (2006) The significance of lysosomal inclusions in Fabry disease. Virchows Arch 449:134PubMedCrossRef
23.
24.
Zurück zum Zitat Sweeley CC, Klionsky B (1963) Fabry’s disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 238:3148–3150PubMed Sweeley CC, Klionsky B (1963) Fabry’s disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 238:3148–3150PubMed
25.
Zurück zum Zitat Tabira T, Goto I, Kuroiwa Y, Kikuchi M (1974) Neuropathological and biochemical studies in Fabry’s disease. Acta Neuropathol (Berl) 30:345–354CrossRef Tabira T, Goto I, Kuroiwa Y, Kikuchi M (1974) Neuropathological and biochemical studies in Fabry’s disease. Acta Neuropathol (Berl) 30:345–354CrossRef
26.
Zurück zum Zitat Tsukada N, Hanu N, Oguchi K, Yanagisawa N, Tsukagoshi H, Hattori H (1980) [Fabry’s disease with malocclusion and acromegalic-appearance: clinical and electronmicroscopic studies (author’s transl)]. No To Shinkei 32:311–319PubMed Tsukada N, Hanu N, Oguchi K, Yanagisawa N, Tsukagoshi H, Hattori H (1980) [Fabry’s disease with malocclusion and acromegalic-appearance: clinical and electronmicroscopic studies (author’s transl)]. No To Shinkei 32:311–319PubMed
Metadaten
Titel
Postmortem diagnosis of Fabry disease with acromegaly and a unique vasculopathy
verfasst von
Masaki Takao
Taisuke Mori
Hideki Orikasa
Haengphil Oh
Kinuko Suzuki
Atsuo Koto
Kazuto Yamazaki
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 3/2007
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0456-x

Weitere Artikel der Ausgabe 3/2007

Virchows Archiv 3/2007 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …